GSK Says FDA Approved Advair 250/50 For Reduction Of Exacerbations … – RTT News
GSK Says FDA Approved Advair 250/50 For Reduction Of Exacerbations ... RTT News, NY - 11 minutes ago ... inhalation powder) for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD) who have a history of exacerbations. ... |